PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, today announced the receipt of written minutes from the End-of-Phase 1 meeting with the U.S.…
Researchers Are Using Machine Learning to Screen for Autism in Children
Parents and doctors face a difficult dilemma when it comes to detecting and treating autism spectrum disorder (ASD) in children. It’s critically important to diagnose ASD as early in a child’s development as possible. Starting treatment…
Top 10 Companies Leveraging Gene Editing in 2019
Bayer made much of its desire to establish a cell therapy pipeline on August 8 when it announced it would shell out up to $600 million to acquire full control of BlueRock Therapeutics. But the…
Hungry for Innovation: Notable Project Stems from MEDx Dinner
On a chilly December evening in Durham guests arrived at The Restaurant at The Durham Hotel with a hunger for food and innovation. Seated around a U-shaped table, gastroenterology and engineering professionals brainstormed engineering solutions…
NC Biotech Center awards $2M in grants, loans across state’s life science ecosystem
The North Carolina Biotechnology Center awarded 22 grants and loans totaling $2,050,778 to universities, bioscience companies and other organizations in the fourth quarter of its fiscal year. The awards, made from April 1 to June 30, will…
Simulating Blood Flow at the Cellular Level
Amanda Randles’s revolutionary supercomputer blood flow simulator HARVEY is poised to improve the diagnosis, prevention and treatment of human diseases Amanda Randles, the Alfred Winborne Mordecai and Victoria Stover Mordecai Assistant Professor of Biomedical Engineering at…
Polarean Enrols First Patient At University Of Cincinnati Trial Site
Polarean Imaging PLC on Monday announced enrolment of the first patients in its third trial site at the University of Cincinnati in the US and is on track for its third quarter enrolment target. Shares…
Askbio new partnership could lead to big gains for gene therapy
By Seth Thomas Gulledge – Staff Writer, Triangle Business Journal Just months after bringing in $235 million in new funding, a Triangle gene-therapy company has landed a big partnership in the first of many moves predicted by its…
Triangle Leads Nation in NIH Per-Capita Funding
North Carolina’s Research Triangle region has another statistic to crow about. A recent study by the State Science & Technology Institute (SSTI) reported that the Durham-Chapel Hill metropolitan area led the nation last year in per-capita funding…